Russian biopharmaceutical company BIOCAD is the first company in the country to launch a 150-million-dollar effort to Supply therapeutic products based on monoclonal antibodies to several countries outside Russia. In […]
This post first appeared on Biotechin.asia – Your Daily Biotech And Healthca, please read the originial post: here
